Key result
Queen of Hearts program targets female-specific blood biomarkers to improve HFpEF diagnosis and risk stratification.
Authors
Loading...
May advance sex-specific HFpEF diagnostics in women; leaves open clinical utility pending prospective validation.
The Dutch Queen of Hearts program aims to discover and validate novel blood-derived biomarkers for diagnosing diastolic dysfunction and HFpEF specifically in women.
Ruijter et al. (2015) conducted a review in Heart failure with preserved ejection fraction (HFpEF). The Queen of Hearts program aims to discover and validate female-specific biomarkers for diastolic dysfunction and HFpEF from blood-derived sources to improve early diagnosis and risk stratification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: